Aleje Jerozolimskie 65/79, 00-697 Warsaw, Poland

Global Heart Pump Devices Market Analysis and In-depth Research on Size, Trends, Top Companies – Boston Scientific, Boston Scientific Cardiology, CryoLife Inc., Medtronic, Edwards Lifesciences, Symetis, Braile Biomédica, Colibri Heart Valve, Abbott

GIVE US A TRY

Global Heart Pump Devices Market Analysis and In-depth Research on Size, Trends, Top Companies – Boston Scientific, Boston Scientific Cardiology, CryoLife Inc., Medtronic, Edwards Lifesciences, Symetis, Braile Biomédica, Colibri Heart Valve, Abbott

Press Release

The Heart Pump Device market analysis gives an examination of various segments that are relied upon to witness the quickest development amid the estimate forecast frame. This market Report covers strategic profiling and in-depth survey of Top key players in the market, comprehensively analyzing their core competencies and analyzes innovative business strategies. Heart Pump Device market study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s Five Forces Analysis.

According to the latest research, global demand for Heart Pump Device Market was valued at approximately USD 1.57 billion in 2017 and expected to reach USD 6.22 billion in 2025 with growing at a healthy CAGR of 18.8%.

FREE | Sample Report Available At https://databridgemarketresearch.com/request-a-sample/?dbmr=global-heart-pump-device-market

Strategic Key attributes of the report:

  • A complete and useful guide for new market aspirants
  • Forecast information will drive strategic, innovative and profitable business plans and SWOT analysis of players will pave the way for growth opportunities, risk analysis, investment feasibility and recommendations
  • Supply and Consumption –In continuation of sales, this section studies supply and consumption for the Heart Pump Device This part also sheds light on the gap between supply and consumption. Import and export figures are also given in this part.
  • Competitors –In this section, various Heart Pump Device industry leading players are studied with respect to their company profile, product portfolio, capacity, price, cost, and revenue.
  • The 360-degree Heart Pump Device overview based on a global and regional level
  • Market share, value, volume, and production capacity is analyzed on global, regional and country level
  • Production Analysis – Production of the Heart Pump Device is analyzed with respect to different regions, types and applications. Here, price analysis of various Heart Pump Device Market key players is also covered.
  • Sales and Revenue Analysis – Both, sales and revenue are studied for the different regions of the Heart Pump Device Another major aspect, price, which plays an important part in the revenue generation, is also assessed in this section for the various regions.
  • Other analyses – Apart from the information, trade and distribution analysis for the Heart Pump Device

Major Business Entities Covered in this Report

  • Abbott,
  • Abiomed,
  • Medtronic,
  • Getinge,
  • Maquet Getinge Group,
  • Syncardia Systems,
  • Teleflex,
  • HeartWare International Inc.,
  • Berlin Heart GmbH,
  • Getinge AB,
  • Fresenius Medical Care,
  • Syncardia Systems,
  • Reliantheart,
  • Terumo Europe NV,
  • Berlin Heart,
  • Jarvik Heart,
  • Cardiacassist,
  • Thoratec Corporation,
  • Jarvik Heart, Inc. among others.

INQUIRE ABOUT REPORT FROM OUR EXPERT’S AT https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-heart-pump-device-market

Abbott:

Abbott founded in 1888 and headquarters in Illinois, U.S., focuses on manufacturing products for diagnostics, medical devices, nutrition and branded generic pharmaceuticals. It operates its business through Established Pharmaceuticals, Nutritionals, Diagnostics, Cardiovascular and Neuromodulation and Others. It offers heart pumps products through its cardiovascular and neuromodulation.

The company has its presence in U.S., China, Germany, Japan, India, The Netherland, Switzerland, Russia, France, Brazil, Italy, U.K., Colombia, Canada, Vietnam and others. It has its subsidiaries worldwide such as Alere Inc. (U.S.), Abbott Medical Optics Inc. (U.S.), EAS (U.S.), Abbott India Ltd (India), Thoratec Corporation (U.S.) and others.

  • In January 2017, Abbott (U.S.) acquired ST. JUDE MEDICAL (U.S.). This acquisition expanded Abbott (U.S.) opportunities for future growth and development of strong, diverse portfolio of devices, diagnostics, nutritionals and branded generic pharmaceuticals.

Getinge AB:

Getinge AB, founded in 1904 and based in Sweden. It is involved in designing, manufacturing and marketing of equipment and systems for healthcare and life sciences. It operates its business through acute care therapies and surgical workflows. It offers heart pump devices through its subsidiary Maquet (Germany). The company has its presence in North America, South America, Asia Pacific, Europe, Middle East and Africa.

  • In Feburary 2014, Getinge AB (Sweden) acquired Pulsion Medical Systems (Germany). This acquisition has expanded business of the company.

Market Segmentation

Based on geography, the market report covers data points for 28 countries across multiple geographies namely

  • North America & South America,
  • Europe,
  • Asia-Pacific and,
  • Middle East & Africa

Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others.

On the basis of therapy, the market is segmented into

  • bridge-to-transplant (BTT),
  • bridge-to-candidacy (BTC),
  • destination therapy (DT) and other therapies

Based on product, the market is segmented into

  • ventricular assist devices (VADs),
  • intra-aortic balloon pumps (IABPs) and t
  • Total artificial heart (TAH)

The ventricular assist devices (VADs) segment is further sub-segmented into left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), Bi-ventricular assist devices (BiVADs) and percutaneous ventricular assist devices (pVADs).

On the basis of type, the market is classified into

  • implantable heart pump devices and
  • extracorporeal heart pump devices

Major Key Points in TABLE OF CONTENTS

  • Introduction
  • MARKET SEGMENTATION
  • Market Overview
  • Drivers
  • Restraints
  • OPPORTUNITIES
  • CHALLENGES
  • EXECUTIVE SUMMARY
  • premium insights
  • Global Heart Pump Device Market, by Geography …Continued

FREE TOC is available at https://databridgemarketresearch.com/toc/?dbmr=global-heart-pump-device-market

Major Drivers of Heart Pump Device Market

Prominent factors driving the growth of this market consist of increasing incidence of cardiac disease, rapid advancement in surgical technique in VAD implantation, increasing popularity of minimal invasive surgical procedures in cardiology, regulatory approval of heart pump devices are fuel the growth of heart pump devices market.

Increasing Incidence of Cardiac Diseases:

According to Health Data Government, world population from past increase 7 billion and increasing the number of geriatric population. So the number of death from cardiovascular diseases is also increasing. As per the European Society of Cardiology in 2014, approximately 26 million people in all over world suffering from heart failure. Cardiac diseases such as heart attacks, strokes and other circulatory disease is the major cause of premature death in the world.

Increasing regulatory approval and reimbursement procedure of heart pump devices:

Regulatory approval is defined as that approvals by government pricing or health authorities in a country (including FDA and EMEA), product and establishment licenses, registrations or authorizations of any federal, state or local regulatory agency, department, bureau or other governmental entity, in each case. These regulatory approvals are necessary for the commercial manufacture, usage, storage, importation, export, transport or sale of collaboration products in a regulatory jurisdiction. Different countries have different regulatory body for medical device licensing. In India, cardiac implantable medical devices are listed under the classification of medical device rules with regulatory approval and registration by the CDSCO (Central Drug Standard Controller Organization).The CDSCO (Central Drug Standard Controller Organization) is govern by the Drug Controller General of India (DCGI).

Customization of the Report:

This report can be customized to meet the client’s requirements. Please connect with our sales team ([email protected]), who will ensure that you get a report that suits your needs.

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Sopan gedam

Data Bridge Market Research

Tel: +1-888-387-2818

Email:  [email protected]

Tags: , , , ,